Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
35.48% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
NTRB · Jul 31, 2022
NutriBand Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001213900-22-054592General Corporate
Evidence method
Level · gp.fundamentals.gross_margin
33.28% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-226.73% · CORE · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History29 statesHistory building
Oct 31, 20213/5 normalizedLevel 3Jan 31, 20225/8 normalizedLevel 3Apr 30, 20224/6 normalizedLevel 3Jul 31, 20223/3 normalizedLevel 3Oct 31, 20224/4 normalizedLevel 3Jan 31, 20235/7 normalizedLevel 3Apr 30, 20236/8 normalizedLevel 3Jul 31, 20236/7 normalizedLevel 3Oct 31, 20234/5 normalizedLevel 3Jan 31, 20247/8 normalizedLevel 3Apr 30, 20247/8 normalizedLevel 3Jul 31, 20245/5 normalizedLevel 3Oct 31, 20245/5 normalizedLevel 3Jan 31, 20258/8 normalizedLevel 3Apr 30, 20257/7 normalizedLevel 3Jul 31, 20257/7 normalizedLevel 3Oct 31, 20257/7 normalizedLevel 3Jan 31, 20268/8 normalizedLevel 3Apr 30, 20267/7 normalizedLevel 3Jul 31, 20266/6 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 26.68%
- Current
- 35.48%
- Delta
- 8.79%
- Previous
- 41.95%
- Current
- 33.28%
- Delta
- -8.67%
- Previous
- -143.51%
- Current
- -226.73%
- Delta
- -83.22%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.